10 cents, or 2.1 percent, to close at $4.91 during the regular trading session. Shares of King Pharmaceuticals, based...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
KING PHARMACEUTICALS (KG)
King Pharmaceuticals, Inc. is the world’s 39th-largest pharmaceutical company. It provides branded prescription pharmaceutical products worldwide It primarily offers branded prescription products for primary care physicians, neurologists, orthopedic surgeons, hospitals, internal medicine physicians, allergists, pediatricians, and pain specialists. Some brands include Altace for heart attack prevention; Levoxyl for hypothyroidism; Sonata for sleeping; and Skelaxin, a muscle relaxant.
King Pharmaceuticals (KG) is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
133 news
and
95 blog
items.
Read updated news, blogs, and resources about King Pharmaceuticals (KG). Find user-submitted articles and reactions on King Pharmaceuticals (KG) from
like-minded professionals.
News
Please add new articles to this topic
business * Shares down 1.9 percent (Recasts, adds stock price) BOSTON, Jan 15 (Reuters) - Specialty drugmaker King...
Extract not available.
Merck, Baxter International and Thermo Fisher Scientific. It has the same number of companies with negative outlooks.
percent Dec 10 (Reuters) - ZymoGenetics Inc (ZGEN.O) said a U.S. district court denied all of King Pharmaceuticals...
and Drug Administration in February had asked manufacturers including Johnson & Johnson (JNJ.N: Quote, Profile,...
prescription painkillers, under pressure from regulators trying to prevent hundreds of fatal overdoses each year.
in debt as of the quarter ended Sept. 30 and has a market cap of $2.6 billion. King Pharmaceuticals sells generic drugs...
Pharmaceuticals * EMD Serono * AstraZeneca * Honeywell * Bayer Schering AG * IDS * Boehringer Ingelheim * King...
Seattle-based biotechnology company said Friday. The three restraining orders resulted from a lawsuit filed by rival...
Extract not available.
Lee BrodieWeb ProducerDrug developer King Pharmaceuticals KGloading...� � �
deal. Its Meridian unit gained 6 percent to $72 million. Royalty revenue fell to $12 million. Shares of King...
NEW YORK - King Pharmaceuticals Inc. and Acura Pharmaceuticals Inc. said Friday they don't expect to have to run new...
programs.' Before Symphogen, Adriann most recently served as Executive Vice President, Corporate Strategy, Strategic...
DOW JONES NEWSWIRES King Pharmaceuticals Inc.(KG) said the U.S. Food and Drug Administration approved Embeda, a...
Dow Jones)- The Food and Drug Administration questioned clinical data involving Corvue, a proposed imaging drug from...
in companies over which they have voting power. Perry's stake in Mylan followed a proposed merger with King...
argued that it wasn’t required to immediately disclose the stake in Mylan, which was trying to buy King Pharmaceuticals...
5 mcg (base), 25 mcg (base) and 50 mcg (base). Liothyronine Sodium Tablets are the generic version of King...
Pill' sales by over 50%. In 2007, a Super Bowl TV spot for the American Heart Association and King Pharmaceuticals led...
comes after FDA meeting * Remoxy pain drug designed to thwart abuse NEW YORK, July 7 (Reuters) - King Pharmaceuticals...
CUPERTINO, Calif., July 7 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) today reported that King...
NEW YORK (MarketWatch) -- King Pharmaceuticals Inc. (KG) said Thursday that it and Acura Pharmaceuticals Inc.
its 2009 outlook to original range it provided entering the year of $690-$720 million. Acura Pharmaceuticals (ACUR) and...
Top Sources: King Pharmaceuticals (KG)
- Reuters
- MarketWatch
- TheStreet.com
- CNBC
- Morningstar.com
- Wall Street Journal Online
- BusinessWeek
- Smart Money
- Motley Fool
- Reuters UK
Most Active Users in this Topic
No user contributions
account